Amgen (NASDAQ:AMGN) and Adaptive Biotechnologies (NASDAQ:ADPT) will host a webinar tomorrow, April 9, at 11:00 am ET to discuss their collaboration to develop a therapeutic to prevent or treat COVID-19.
Amgen EVP of R&D David Reese, M.D. and Adaptive co-founder and CSO Harlan Robins, Ph.D. will lead.
https://seekingalpha.com/news/3559217-amgen-adaptive-biotech-set-webinar-on-covidminus-19-drug-partnership
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.